NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
A leading provider of oncology diagnostic solutions that enable precision medicine, today announced preliminary fourth quarter and full-year 2025 revenue and also announced a transition of the Company’s Chief...

